Atlantic Health System
LiviWell has developed a product designed for postcoital semen absorption. Previous studies have demonstrated the product rapidly absorbs semen, and leads to less symptoms of postcoital vaginal microbiome disruption such as vaginal odor and discharge. This study will investigate the study device, Livi, in a broader clinical setting.
LiviWell's consumer hygiene device is a post-coital vaginal insert called "Livi". Livi is comprised of an applicator, with a medical-grade polyurethane foam and retrieval string. It is designed to be inserted into the vagina after intercourse to absorb semen deposited into the vaginal canal. The result is a decrease in discharge/dripping and vaginal odor. The investigators also believe the device will lower vaginal pH, as the typical premenopausal vaginal pH is acidic (pH \~4), and semen has an alkaline pH (\~8). The resulting pH imbalance in sexually-active women not using male condoms had be…
Inclusion Criteria: * Over 18 (for pH subset, 18-45) * Sexually-active with biological men * Willing and able to use product * Resides in continental USA * Understands, reads, writes, and speaks English Exclusion Criteria: * Currently Pregnant or are trying to conceive * Unable to use device due to poor motor function * Unable to sign informed consent
subjects will use Livi within minutes of completion of sex, and will remove study device in under an hour.
Arctuva estimate
Verify or correct the compensation shown for this listing.